Eikon Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| – | -6.6% | +21.1% | |
| – | -47.8% | +53.1% | |
| – | +14.5% | -18.8% | |
| – | – | – | |
| – | +22.6% | +38.6% | |
| – | +79.5% | -2.6% | |
| – | – | – | |
| – | +703.7% | -96.1% | |
| – | – | – | |
| – | – | – | |
| – | +0.0% | +0.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.